Stocks and Investing Stocks and Investing
Thu, February 27, 2020
Wed, February 26, 2020

David Lebovitz Maintained (ASND) at Buy with Increased Target to $181 on, Feb 26th, 2020


Published on 2024-10-26 22:39:52 - WOPRAI, David Lebovitz
  Print publication without navigation


David Lebovitz of Morgan Stanley, Maintained "Ascendis Pharma A/S" (ASND) at Buy with Increased Target from $148 to $181 on, Feb 26th, 2020.

David, nor any peers, have made any analyst calls on ASND in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources